PMID: 30026408Jul 22, 2018Paper

Clinical Practice of Carcinoma of Unknown Primary

Gan to kagaku ryoho. Cancer & chemotherapy
Yoriko Hasegawa, Hirofumi Mukai

Abstract

Carcinoma of unknown primary(CUP)is defined as the presence of metastatic cancer documented in the absence of an identifiable primary tumor site. According to this definition, between 1% and 5% of cancer patients are diagnosed with this clinical entity. CUPs are a heterogeneous group of neoplasms with widely varying natural histories and biologic characteristics. In this broad category, there are 5 major diagnoses, as assessed by light microscopy: (1)poorly differentiated neoplasm,(2) well differentiated and moderately differentiated adenocarcinoma,(3)squamous cell carcinoma(4)neuroendocrine tumor, and(5)poorly differentiated carcinoma(with or without features of adenocarcinoma) .It has been reported that the prognosis of patients with CUP is poor. The median survival time(MST)is 6 to 9 months, and less than 25% of the CUP patients are alive 1 year after diagnosis. Previous trials with a variety of chemotherapeutic regimens have produced response rates of less than 50% with negligible benefit in terms of median survival. Platinum -containing regimens have induced higher response rates than those without it in patients with CUP, and platinum is considered a key drug in UPC treatment.

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

Revista clínica española
M J Fernández Cotarelo, J M Guerra Vales
Journal of the National Comprehensive Cancer Network : JNCCN
David S EttingerNational Comprehensive Cancer Network
© 2022 Meta ULC. All rights reserved